ArticleNature communications2023

Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer.

Lingzhi Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.